Taken together, it is likely that sympathetic nerve-derived NPY may be pathogenic in CKD patients by stimulating vasoconstriction, whereas macrophage-derived NPY may be immunogenic and functions as an immunoregulator to protect kidney from AKI by inhibiting M1 macrophages and renal inflammation. The gene discussed is NPY; the disease is chronic kidney disease.